Financial Survey: Utah Medical Products (NASDAQ: UTMD) and Isoray (NYSE: ISR)
Isoray (NYSE:ISR – Get Rating) and Utah Medical Products (NASDAQ:UTMD – Get Rating) are both small-cap medical companies, but which business is superior? We will compare the two companies based on the strength of their institutional ownership, earnings, dividends, analyst recommendations, valuation, risk and profitability.
Volatility and risk
Isoray has a beta of 1.02, indicating its stock price is 2% more volatile than the S&P 500. In comparison, Utah Medical Products has a beta of 0.25, indicating its stock price is 75% less volatile than the S&P 500.
Benefits and evaluation
This table compares the revenue, earnings per share and valuation of Isoray and Utah Medical Products.
|Gross revenue||Price/sales ratio||Net revenue||Earnings per share||Price/earnings ratio|
|Isoray||$10.05 million||3.96||-$3.39 million||($0.05)||-5.60|
|Utah Medical Products||$49.05 million||6:30 p.m.||$14.79 million||$4.18||8:31 p.m.|
Utah Medical Products has higher revenues and profits than Isoray. Isoray trades at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks.
This table compares the net margins, return on equity and return on assets of Isoray and Utah Medical Products.
|Net margins||Return on equity||return on assets|
|Utah Medical Products||30.34%||14.11%||12.96%|
Institutional and insider ownership
12.4% of Isoray shares are held by institutional investors. By comparison, 71.4% of Utah Medical Products’ stock is held by institutional investors. 2.4% of Isoray shares are held by company insiders. By comparison, 6.6% of Utah Medical Products’ stock is held by company insiders. Strong institutional ownership indicates that large fund managers, endowments, and hedge funds believe a stock is poised for long-term growth.
This is a breakdown of current recommendations for Isoray and Utah Medical Products, as reported by MarketBeat.
|Sales Ratings||Hold odds||Buy reviews||Strong buy odds||Rating|
|Isoray||0||0||0||0||N / A|
|Utah Medical Products||0||0||0||0||N / A|
Utah Medical Products beats Isoray on 10 of 11 factors compared between the two stocks.
About Isoray (Get a rating)
Isoray, Inc., through its subsidiary IsoRay Medical, Inc., develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and throughout the world. The company offers Cesium-131 CS-1 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal and colorectal cancers. It sells its products to institutions or medical practices that use various surgical facilities. Isoray, Inc. was founded in 1998 and is based in Richland, Washington.
About Utah Medical Products (Get a rating)
Utah Medical Products, Inc. develops, manufactures and distributes medical devices for the healthcare industry. The Company offers fetal monitoring accessories, vacuum assisted delivery systems and other labor and delivery tools; Respiratory hoods for newborns DISPOSA-HOOD; and DELTRAN PLUS blood pressure monitoring systems. It also supplies GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE Silicone Mouthguards; URI-CATH urinary drainage systems; NUTRI-CATHNUTRI-LOK feeding device; MYELO-NATE Lumbar Sampling Kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. Additionally, the Company offers the LETZ System for excision of cervical intraepithelial neoplasia and other lower genital tract lesions; FINESSE+ generators; loop, ball and needle electrodes; FILTRESSE spillways; other electrodes and specialized supplies and gynecological tools; Femcare trocars, cannulas, laparoscopic instruments and accessories; and EPITOME and OptiMicro electrosurgical devices. In addition, it provides Filshie Clip female surgical contraceptive devices; PATHFINDER PLUS endoscopic irrigation devices; suprapubic catheterization; LIBERTY Urinary Incontinence Treatment and Control Systems; ENDOCURETTE, a curette for the removal of uterine endometrial tissue; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of the uterus; and the LUMIN tool for manipulating the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components and other castings. It serves neonatal intensive care units, labor and delivery wards, women’s health centers in hospitals, outpatient clinics and physicians’ offices through direct customer service and a force sales representatives, independent consultants and manufacturer representatives. The company was incorporated in 1978 and is headquartered in Midvale, Utah.
Get news and reviews for Isoray Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Isoray and related companies with MarketBeat.com’s free daily email newsletter.